I believe metabolomics has the potential to shed light into the pathophysiology behind glaucomatous damage, as well as providing potential biomarkers for early glaucoma detection.
Metabolomics is the detailed study of metabolites created by the cellular processes in an organism. Influenced by both genetic and environmental factors, the metabolite profile gives us a “fingerprint” of the health status of the organism at the time of sampling. But aside from disease mechanisms and biomarkers, this technology has also been increasingly used for drug target discovery and the prediction of drug effects – and it can help move medical care towards a more personalized approach.
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
If you don’t have an account you can:
REGISTER NOW – it’s FREE and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login as a Guest or via Social Media
This will allow you to read this article but you will only have limited access to The Ophthalmologist.Login as Guest Twitter LinkedIn Google+ Facebook